Web-Based End-of-Life Planning Tool for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This clinical trial examines a web-based tool, in partnership with Peacefully, Inc, designed to improve end-of-life planning among patients with advanced cancers. This program helps users prepare comprehensively for end-of-life (e.g., medical wishes, legal estate planning, financial planning and transfer of accounts, legacy building, and emotional support). It is expected that this web-based end-of-life planning program may reduce distress and improve end-of-life preparation among advanced cancer patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is the Web-Based End-of-Life Planning Tool safe for use in humans?
How is the Web-Based End-of-Life Planning Tool for Cancer different from other treatments?
The Web-Based End-of-Life Planning Tool, also known as Peacefully, is unique because it is an online resource designed to help cancer patients and healthcare providers discuss and plan for end-of-life care, focusing on quality of life and advance care planning. Unlike traditional treatments that focus on medical interventions, this tool facilitates communication and decision-making about end-of-life preferences.23467
What data supports the effectiveness of the treatment Web-Based Tool for End-of-Life Planning, Peacefully, Web-Based End-of-Life Planning Tool?
Research suggests that web-based tools for advance care planning can improve communication among patients, families, and healthcare providers, and help in identifying and addressing patient needs more effectively. These tools have been explored in various conditions, such as ovarian cancer and lung disease, indicating their potential to support end-of-life planning.2891011
Who Is on the Research Team?
Megan J Shen, PhD.
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Are You a Good Fit for This Trial?
This trial is for adults with advanced cancer, who have a life expectancy of less than 12 months and have undergone at least one round of chemotherapy. Participants must be able to use a computer or mobile device, give informed consent, and speak English fluently. Those severely cognitively impaired or too ill to complete interviews are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Patients receive Peacefully's web-based tool to help with end-of-life planning on day 7
Control
Patients receive standard care
Follow-up
Participants are monitored for changes in well-being and end-of-life planning engagement
What Are the Treatments Tested in This Trial?
Interventions
- Web-Based Tool for End-of-Life Planning
Web-Based Tool for End-of-Life Planning is already approved in United States for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer Center
Lead Sponsor
Peacefully, Inc.
Collaborator
National Institute of Nursing Research (NINR)
Collaborator